"L\u00E9\u010Dba akutn\u00EDch lymfoblastov\u00FDch leuk\u00E9mi\u00ED u dosp\u011Bl\u00FDch : mo\u017Enost intenzifikace protokolu CALGB 8811 vysokod\u00E1vkovan\u00FDm cytosinarabinosidem a metotrex\u00E1tem."@cs . . "0"^^ . "0"^^ . "lymphoblastic leukaemia; cytosinarabinoside; methotrexate"@en . "1"^^ . . . "Transfuze a hematologie dnes" . . "8" . "Koz\u00E1k, T." . "4;12" . "RIV/00023736:_____/02:00000061!RIV/2003/MZ0/L33003/N" . . . "651655" . . "1" . "[540E077C1CB0]" . . "Proch\u00E1zka, B." . "RIV/00023736:_____/02:00000061" . "9"^^ . . . "L\u00E9\u010Dba akutn\u00EDch lymfoblastov\u00FDch leuk\u00E9mi\u00ED u dosp\u011Bl\u00FDch : mo\u017Enost intenzifikace protokolu CALGB 8811 vysokod\u00E1vkovan\u00FDm cytosinarabinosidem a metotrex\u00E1tem." . "L\u00E9\u010Dba akutn\u00EDch lymfoblastov\u00FDch leuk\u00E9mi\u00ED u dosp\u011Bl\u00FDch : mo\u017Enost intenzifikace protokolu CALGB 8811 vysokod\u00E1vkovan\u00FDm cytosinarabinosidem a metotrex\u00E1tem."@cs . "CZ - \u010Cesk\u00E1 republika" . . "V\u00FDsledky l\u00E9\u010Dby 15 pacient\u016F s ALL upraven\u00FDm protokolem CALGB 8811 s c\u00EDlem zjistit sch\u016Fdnost ambulantn\u00EDho pod\u00E1n\u00ED intenzivn\u00ED f\u00E1ze l\u00E9\u010Dby a mo\u017Enosti intenzifikace p\u016Fvodn\u00EDho protokolu vysokod\u00E1vkovan\u00FDm cytosinarabinosidem a metotrex\u00E1tem." . "P(NK5937), Z(MSM 111100004)" . "L\u00E9\u010Dba akutn\u00EDch lymfoblastov\u00FDch leuk\u00E9mi\u00ED u dosp\u011Bl\u00FDch : mo\u017Enost intenzifikace protokolu CALGB 8811 vysokod\u00E1vkovan\u00FDm cytosinarabinosidem a metotrex\u00E1tem." . "Lymphoblastic leukaemia in adults : possibilities of intensification of CALGB 8811 protocol with high-dose cytosinarabinoside and methotrexate."@en . "Lymphoblastic leukaemia in adults : possibilities of intensification of CALGB 8811 protocol with high-dose cytosinarabinoside and methotrexate."@en . "Pytl\u00EDk, R." . "Gregora, E." . . . "5"^^ . "Maaloufov\u00E1, Jacqueline" . . . "1213-5763" . . . "The results of 15 ALL patients using a modification of the CALGB 8811 protocol. The aim was to determine the feasibility of delivering the intensive phase of treatment in an outpatient setting and of intensifying the original protocol using high-dose cytosinarabinoside and methotrexate."@en .